Dear Researchers,

The Innovative Medicines Initiative (IMI) 2- call 20 is open for proposals.

Eligible applicants are consortia with a minimum of 3 research teams (organizations) from 3 different EU-countries or associated countries. Applicants can be universities, research institutions, hospitals etc. It is encouraged to include SMEs which will also get funding through the project.

The call is a standard two-stage call for proposals with the following topics:

§ Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis

§ Topic 2: Innovations to accelerate vaccine development and manufacture

§ Topic 3: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
This topic is part of the IMI AMR Accelerator Programme.

§ Topic 4: Tumour plasticity

§ Topic 5: Proton versus photon therapy for oesophageal cancer – a trimodality strategy

§ Topic 6: Handling of protein drug products and stability concerns

Deadline for short proposals: 21 April 2020.

Call web page: http://bit.ly/imi2call20

Webinars

IMI is currently running webinars on IMI2 – Call 10, including webinars on all Call topics, as well as IMI’s rules and procedures and opportunities for small and medium-sized enterprises (SMEs).

Tips on finding partners and preparing your proposal

The IMI website includes pages with advice for applicants and guidance on how to find project partners.

Best regards,

Emma

************************

Emma Pirilä, PhD

Research Funding Specialist

Faculty of Medicine

Faculty of Biochemistry and Molecular Medicine

Biocenter Oulu

Aapistie 5A, 2nd floor

FIN- 90230 University of Oulu

Finland

Phone: +358503426428

e-mail: emma.pirila@oulu.fi

************************